CRYAB modulates the activation of CD4+ T cells from relapsing-remitting multiple sclerosis patients. Quach Q L, Metz LM, Thomas JC, Rothbard JB, Steinman L, Ousman SS Mult Scler. 2013 Jun 4. PMID: 23736536. Abstract CommentRecommendBookmarkWatch